15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
Open accessThe DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index; 86 of the 155 sources its claims cite were checked for support.
Abstract
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
CoChat Summary
TL;DR
This ADA Standards of Care section summarizes clinical practice recommendations for managing diabetes in pregnancy, covering preconception care, glycemic targets, gestational diabetes, preexisting type 1/type 2 diabetes, preeclampsia prevention, and postpartum care. It is a guideline synthesis rather than a primary study, with recommendations graded by available evidence.
Key findings
- Preconception care should target A1C <6.5% (<48 mmol/mol) to reduce congenital anomalies, preeclampsia, macrosomia, and preterm birth; preconception care in preexisting diabetes was associated with lower A1C and reduced birth defects, preterm delivery, perinatal mortality, small-for-gestational-age births, and NICU admissions.
- Pregnancy glucose goals are fasting plasma glucose <95 mg/dL (<5.3 mmol/L) and either 1-h postprandial <140 mg/dL (<7.8 mmol/L) or 2-h postprandial <120 mg/dL (<6.7 mmol/L); A1C goal is <6% (<42 mmol/mol) if achievable without significant hypoglycemia, relaxed to <7% (<53 mmol/mol) if needed. CGM is recommended in type 1 diabetes pregnancy, with target sensor range 63–140 mg/dL (3.5–7.8 mmol/L) and TIR goal >70%.
- For GDM, lifestyle behavior change is essential and may suffice; insulin is preferred when medication is needed. Metformin and glyburide should not be first-line because both cross the placenta; 70–85% of people with GDM by Carpenter-Coustan criteria can manage with lifestyle alone, while glyburide and metformin failed adequate glycemic outcomes in 23% and 25–28% of participants, respectively.
- Postpartum, GDM history should be screened at 4–12 weeks with a 75-g OGTT; lifetime maternal diabetes risk is 50–60%, with a 10-fold increased risk of type 2 diabetes versus no GDM. Lifestyle intervention and metformin reduced progression to diabetes by 35% and 40%, respectively, over 10 years; insulin requirements are often roughly half prepregnancy levels initially postpartum, and one study found they were 34% lower.
Methods
- This is an ADA “Standards of Care in Diabetes—2024” clinical practice guideline section, produced by the ADA Professional Practice Committee, which updates recommendations annually or more frequently as warranted.
- It synthesizes evidence from observational studies, RCTs, systematic reviews, and meta-analyses; no new primary data collection or trial is reported.
- Recommendations are organized across preconception counseling, glycemic goals, glucose monitoring, GDM management, preexisting type 1 and type 2 diabetes, preeclampsia/aspirin, pregnancy drug considerations, and postpartum care.
Limitations
- The paper states there are no adequately powered randomized trials comparing different fasting and postmeal glycemic goals for preexisting diabetes in pregnancy; data are insufficient to support CGM in all people with type 2 diabetes or GDM; long-term safety data for offspring exposed to glyburide are not available; and there are no intervention trials in offspring of mothers with GDM.
- It also notes that the most appropriate hypoglycemia threshold in pregnancy has not been validated, and that observational preconception A1C data are confounded by other self-care behaviors.
- Evident from the text: several recommendations rely on expert opinion or limited evidence, including some graded E, and some management decisions are individualized because of insufficient data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
69 Valid · 3 Not valid · 30 Not checked · 1 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, the presence of microvascular complications is associated with higher risk of disease progression and adverse pregnancy outcomes (22).”
What the sources say
- Supportedcites [22] Relph, 2021, Adverse pregnancy outcomes in women with diabetes-related microvascular disease and risks of disease progression in pregnancy: A systematic review and meta-analysis, PLoS Med source
The Discussion’s Main findings section reports greater risks of adverse maternal and offspring outcomes in pregnant women with preexisting diabetes and microvascular disease. The Results table on risk factors for progression also associates existing retinopathy and nephropathy with worsening or new-onset retinopathy during pregnancy. The claim is supported in this pregnancy-and-diabetes context. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There are insufficient data to support the use of CGM in all people with type 2 diabetes or GDM (53,54).”
What the sources say
- Not checked — no full text of the sourcecites [53] García-Moreno, 2022, Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials, Diabet Med source
- Partly supportedcites [54] Wyckoff, 2021, Time in range in pregnancy: is there a role?, Diabetes Spectr sourceExperimental — accuracy not yet measured
The section on trials in type 2 diabetes or GDM says that CGM outcomes data are far less robust, with no RCTs specifically studying type 2 diabetes in pregnancy and limited data for GDM. That supports caution about universal CGM use during pregnancy, but the source does not address all people with type 2 diabetes outside pregnancy, as the citing sentence could imply. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The cost of CGM in pregnancies complicated by type 1 diabetes is offset by improved maternal and neonatal outcomes (52).”
What the sources say
- Supportedcites [52] Ahmed, 2021, The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes in 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial, CMAJ Open source
The Interpretation conclusion says that, for pregnant patients with type 1 diabetes, governments could pay up to $1372 for CGM devices and sensors without increasing overall costs compared with SMBG, while improving maternal and neonatal outcomes. The Abstract Interpretation attributes the cost balance in part to lower neonatal intensive care costs. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In studies of individuals without preexisting diabetes, increasing A1C levels within the normal range are associated with adverse outcomes (38).”
What the sources say
- Partly supportedcites [38] Ho, 2017, Associations of mid-pregnancy HbA1c with gestational diabetes and risk of adverse pregnancy outcomes in high-risk Taiwanese women, PLoS One sourceExperimental — accuracy not yet measured
The Discussion and Results (Table 1; page numbers unavailable) associate higher mid-pregnancy HbA1c with several adverse pregnancy outcomes among women without overt diabetes, including at levels below 6.0%. The study is limited to high-risk pregnant Taiwanese women with positive glucose-challenge screens, so it does not establish the claim for individuals generally; the Discussion also describes the overall risk pattern as J-shaped, not uniformly increasing. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Observational studies in preexisting diabetes and pregnancy show the lowest rates of adverse fetal outcomes in association with A1C <6-6.5% (<42-48 mmol/mol) early in gestation (4-6,40).”
What the sources say
- Partly supportedcites [4] Jensen, 2009, Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes, Diabetes Care sourceExperimental — accuracy not yet measured
Table 1 and the Results show the lowest observed rate of serious adverse outcomes in the lowest peri-conceptional A1C category, <6.9%, among women with type 1 diabetes. The paper does not distinguish outcomes below 6–6.5% or establish that narrower range as the lowest-risk threshold; its conclusion supports a preconceptional A1C target of <7%. (LLM, conf=0.88)
- Partly supportedcites [5] Suhonen, 2000, Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus, Diabetologia sourceExperimental — accuracy not yet measured
The Results (p. 3) show the lowest observed major-malformation rate in the HbA1c <5.6% group, measured before 14 weeks of gestation. This supports an association between lower early-pregnancy HbA1c and fewer malformations, but the paper does not establish a 6–6.5% cutoff or assess adverse fetal outcomes broadly; its study population was women with Type I diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [6] Nielsen, 2006, HbA1c in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes, Diabetes Care source
- Not checked — no full text of the sourcecites [40] Maresh, 2015, Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes, Diabetes Care source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
61 more claims · 35 with their cited sources checked
Create a free account to see all 103 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 37
- Probably not a substantial claim. 1
Citations
Cites
Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect
Victora, C. G., Bahl, R., Barros, A. J. D., França, G. V. A., Horton, S., Krasevec, J., Murch, S., Sankar, M. J., Walker, N., & Rollins, N. C. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01024-7 · Cited by 8,040
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Weight Gain During Pregnancy: Reexamining the Guidelines
Rasmussen, K. M., & Yaktine, A. L. (2009) · Cited by 4,473
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704559 · Cited by 2,287
Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., & Ishaku, S. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10803 · Cited by 2,089
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies
Duckitt, K., & Harrington, D. (2005) · BMJ · doi:10.1136/bmj.38380.674340.e0 · Cited by 1,784
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Dabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277
Vounzoulaki, E., Khunti, K., Abner, S. C., Tan, B. K., Davies, M. J., & Gillies, C. L. (2020) · BMJ · doi:10.1136/bmj.m1361 · Cited by 1,150
Self-citationClomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063971 · Cited by 1,027
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy
(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003020 · Cited by 871
Ratner, R. E., Christophi, C. A., Metzger, B. E., Dabelea, D., Bennett, P. H., Pi-Sunyer, X., Fowler, S., Kahn, S. E., & The Diabetes Prevention Program Research Group (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0772 · Cited by 867
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study
Villamor, E., & Cnattingius, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69473-7 · Cited by 756
The importance of nutrition in pregnancy and lactation: lifelong consequences
Marshall, N. E., Abrams, B., Barbour, L. A., Catalano, P., Christian, P., Friedman, J. E., Hay, W. W., Hernandez, T. L., Krebs, N. F., Oken, E., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.12.035 · Cited by 709
Less-Tight versus Tight Control of Hypertension in Pregnancy
Magee, L. A., von Dadelszen, P., Rey, E., Ross, S., Asztalos, E., Murphy, K. E., Menzies, J., Sanchez, J., Singer, J., Gafni, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404595 · Cited by 672
de Veciana, M., Major, C. A., Morgan, M. A., Asrat, T., Toohey, J. S., Lien, J. M., & Evans, A. T. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331901 · Cited by 666
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis
Roberge, S., Bujold, E., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.561 · Cited by 628
Lowe, W. L., Scholtens, D. M., Kuang, A., Linder, B., Lawrence, J. M., Lebenthal, Y., McCance, D., Hamilton, J., Nodzenski, M., Talbot, O., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1646 · Cited by 574
Treatment for mild chronic hypertension during pregnancy
Tita, A. T., Szychowski, J. M., Boggess, K., Dugoff, L., Sibai, B., Lawrence, K., Hughes, B. L., Bell, J., Aagaard, K., Edwards, R. K., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2201295 · Cited by 567
Duration of Lactation and Incidence of Type 2 Diabetes
Stuebe, A. M. (2005) · JAMA · doi:10.1001/jama.294.20.2601 · Cited by 505
Balsells, M., Garcia-Patterson, A., Sola, I., Roque, M., Gich, I., & Corcoy, R. (2015) · BMJ · doi:10.1136/bmj.h102 · Cited by 498
ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002960 · Cited by 470
Aroda, V. R., Christophi, C. A., Edelstein, S. L., Zhang, P., Herman, W. H., Barrett-Connor, E., Delahanty, L. M., Montez, M. G., Ackermann, R. T., Zhuo, X., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3761 · Cited by 467
Koivusalo, S. B., Rönö, K., Klemetti, M. M., Roine, R. P., Lindström, J., Erkkola, M., Kaaja, R. J., Pöyhönen-Alho, M., Tiitinen, A., Huvinen, E., et al. (2016) · Diabetes Care · doi:10.2337/dc15-0511 · Cited by 436
Wang, C., Wei, Y., Zhang, X., Zhang, Y., Xu, Q., Sun, Y., Su, S., Zhang, L., Liu, C., Feng, Y., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.01.037 · Cited by 416
Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study
Jovanovic-Peterson, L., Peterson, C. M., Reed, G. F., Metzger, B. E., Mills, J. L., Knopp, R. H., & Aarons, J. H. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90637-7 · Cited by 411
Metabolic Control and Progression of Retinopathy: The Diabetes in Early Pregnancy Study
Chew, E. Y., Mills, J. L., Metzger, B. E., Remaley, N. A., Jovanovic-Peterson, L., Knopp, R. H., Conley, M., Rand, L., Simpson, J. L., Holmes, L. B., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.631 · Cited by 402
Hartling, L., Dryden, D. M., Guthrie, A., Muise, M., Vandermeer, B., & Donovan, L. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00661 · Cited by 395
Langer, O., Levy, J., Brustman, L., Anyaegbunam, A., Merkatz, R., & Divon, M. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90371-2 · Cited by 376
Treatment of hypertension in pregnant women
Sibai, B. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350407 · Cited by 366
Hoffman, M. K., Goudar, S. S., Kodkany, B. S., Metgud, M., Somannavar, M., Okitawutshu, J., Lokangaka, A., Tshefu, A., Bose, C. L., Mwapule, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32973-3 · Cited by 360
Bullo, M., Tschumi, S., Bucher, B. S., Bianchetti, M. G., & Simonetti, G. D. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196352 · Cited by 334
HbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331
Maternal postprandial glucose levels and infant birth weight: The Diabetes in Early Pregnancy Study
Jovanovic‐Peterson, L., Peterson, C., Reed, G., Metzger, B., Mills, J., Knopp, R., & Aarons, J. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90499-u · Cited by 322
Poor pregnancy outcome in women with type 2 diabetes
Clausen, T. D., Mathiesen, E., Ekbom, P., Hellmuth, E., Mandrup-Poulsen, T., & Damm, P. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.323 · Cited by 318
Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0853 · Cited by 315
Relationship of Fetal Macrosomia to Maternal Postprandial Glucose Control During Pregnancy
Combs, C. A., Gunderson, E., Kitzmiller, J. L., Gavin, L. A., & Main, E. K. (1992) · Diabetes Care · doi:10.2337/diacare.15.10.1251 · Cited by 315
Scholtens, D. M., Kuang, A., Lowe, L. P., Hamilton, J., Lawrence, J. M., Lebenthal, Y., Brickman, W. J., Clayton, P., Ma, R. C., McCance, D., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2021 · Cited by 310
Rowan, J. A., Rush, E. C., Plank, L. D., Lu, J., Obolonkin, V., Coat, S., & Hague, W. M. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000456 · Cited by 305
Suhonen, L., Hiilesmaa, V., & Teramo, K. (2000) · Diabetologia · doi:10.1007/s001250050010 · Cited by 302
Palomba, S., Orio, F., Falbo, A., Manguso, F., Russo, T., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0110 · Cited by 279
ACOG Committee Opinion No. 762: Prepregnancy counseling
(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003013 · Cited by 272
Hebert, M., Ma, X., Naraharisetti, S., Krudys, K., Umans, J., Hankins, G., Caritis, S., Miodovnik, M., Mattison, D., Unadkat, J., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.5 · Cited by 252
Obesity in Pregnancy: ACOG Practice Bulletin, Number 230
(2021) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004395 · Cited by 252
Tarry-Adkins, J. L., Aiken, C. E., & Ozanne, S. E. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002848 · Cited by 251
Forlenza, G. P., Li, Z., Buckingham, B. A., Pinsker, J. E., Cengiz, E., Wadwa, R. P., Ekhlaspour, L., Church, M. M., Weinzimer, S. A., Jost, E., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0771 · Cited by 246
Self-citationPlacental passage of metformin in women with polycystic ovary syndrome
Vanky, E., Zahlsen, K., Spigset, O., & Carlsen, S. M. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.051 · Cited by 245
Statins and congenital malformations: cohort study
Bateman, B. T., Hernandez-Diaz, S., Fischer, M. A., Seely, E. W., Ecker, J. L., Franklin, J. M., Desai, R. J., Allen-Coleman, C., Mogun, H., Avorn, J., et al. (2015) · BMJ · doi:10.1136/bmj.h1035 · Cited by 236
Feig, D. S., Donovan, L. E., Zinman, B., Sanchez, J. J., Asztalos, E., Ryan, E. A., Fantus, I. G., Hutton, E., Armson, A. B., Lipscombe, L. L., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30310-7 · Cited by 234
Li, Z., Cheng, Y., Wang, D., Chen, H., Chen, H., Ming, W.-K., & Wang, Z. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3076463 · Cited by 231
Wahabi, H. A., Alzeidan, R. A., Bawazeer, G. A., Alansari, L. A., & Esmaeil, S. A. (2010) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-10-63 · Cited by 228
Jensen, D. M., Korsholm, L., Ovesen, P., Beck-Nielsen, H., Moelsted-Pedersen, L., Westergaard, J. G., Moeller, M., & Damm, P. (2009) · Diabetes Care · doi:10.2337/dc08-2061 · Cited by 227
Metformin vs insulin in the management of gestational diabetes: a meta-analysis
Gui, J., Liu, Q., & Feng, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064585 · Cited by 222
García-Patterson, A., Gich, I., Amini, S. B., Catalano, P. M., de Leiva, A., & Corcoy, R. (2010) · Diabetologia · doi:10.1007/s00125-009-1633-z · Cited by 220
Tobias, D. K., Hu, F. B., Chavarro, J., Rosner, B., Mozaffarian, D., & Zhang, C. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.3747 · Cited by 219
Mathiesen, E. R., Hod, M., Ivanisevic, M., Duran Garcia, S., Brøndsted, L., Jovanovič, L., Damm, P., McCance, D. R., & on behalf of the Detemir in Pregnancy Study Group (2012) · Diabetes Care · doi:10.2337/dc11-2264 · Cited by 219
Guerin, A., Nisenbaum, R., & Ray, J. G. (2007) · Diabetes Care · doi:10.2337/dc07-0278 · Cited by 215
Dennison, R. A., Chen, E. S., Green, M. E., Legard, C., Kotecha, D., Farmer, G., Sharp, S. J., Ward, R. J., Usher-Smith, J. A., & Griffin, S. J. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108625 · Cited by 214
Population pharmacokinetics of metformin in late pregnancy
Charles, B., Norris, R., Xiao, X., & Hague, W. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000184161.52573.0e · Cited by 212
Kristensen, K., Ögge, L. E., Sengpiel, V., Kjölhede, K., Dotevall, A., Elfvin, A., Knop, F. K., Wiberg, N., Katsarou, A., Shaat, N., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4850-0 · Cited by 210
Holmes, V. A., Young, I. S., Patterson, C. C., Pearson, D. W. M., Walker, J. D., Maresh, M. J. A., McCance, D. R., & for the Diabetes and Pre-eclampsia Intervention Trial Study Group (2011) · Diabetes Care · doi:10.2337/dc11-0244 · Cited by 205
Hanem, L. G. E., Stridsklev, S., Júlíusson, P. B., Salvesen, Ø., Roelants, M., Carlsen, S. M., Ødegård, R., & Vanky, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02419 · Cited by 199
Farrar, D., Tuffnell, D. J., West, J., & West, H. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005542.pub3 · Cited by 194
Viana, L. V., Gross, J. L., & Azevedo, M. J. (2014) · Diabetes Care · doi:10.2337/dc14-1530 · Cited by 187
Xie, W., Dai, P., Qin, Y., Wu, M., Yang, B., & Yu, X. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-02892-1 · Cited by 182
Palomba, S., Orio, F., Nardo, L. G., Falbo, A., Russo, T., Corea, D., Doldo, P., Lombardi, G., Tolino, A., Colao, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0689 · Cited by 177
Different types of dietary advice for women with gestational diabetes mellitus
Han, S., Middleton, P., Shepherd, E., Van Ryswyk, E., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009275.pub3 · Cited by 177
Hod, M., Damm, P., Kaaja, R., Visser, G. H. A., Dunne, F., Demidova, I., Hansen, A.-S. P., & Mersebach, H. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.08.005 · Cited by 176
Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes
Maresh, M. J. A., Holmes, V. A., Patterson, C. C., Young, I. S., Pearson, D. W. M., Walker, J. D., & McCance, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-1755 · Cited by 175
Patterns of Glycemia in Normal Pregnancy
Hernandez, T. L., Friedman, J. E., Van Pelt, R. E., & Barbour, L. A. (2011) · Diabetes Care · doi:10.2337/dc11-0241 · Cited by 170
Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study
Mosca, A., Paleari, R., Dalfrà, M. G., Di Cianni, G., Cuccuru, I., Pellegrini, G., Malloggi, L., Bonomo, M., Granata, S., Ceriotti, F., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.064899 · Cited by 161
Griffith, R. J., Alsweiler, J., Moore, A. E., Brown, S., Middleton, P., Shepherd, E., & Crowther, C. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012394.pub3 · Cited by 149
Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes
Taguchi, N., Rubin, E. T., Hosokawa, A., Choi, J., Ying, A. Y., Moretti, M. E., Koren, G., & Ito, S. (2008) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.06.009 · Cited by 142
Hernandez, T. L., Van Pelt, R. E., Anderson, M. A., Daniels, L. J., West, N. A., Donahoo, W. T., Friedman, J. E., & Barbour, L. A. (2014) · Diabetes Care · doi:10.2337/dc13-2411 · Cited by 141
HbA1c in Early Diabetic Pregnancy and Pregnancy Outcomes
Nielsen, G. L., Møller, M., & Sørensen, H. T. (2006) · Diabetes Care · doi:10.2337/dc06-0914 · Cited by 140
Hanem, L. G. E., Salvesen, Ø., Juliusson, P. B., Carlsen, S. M., Nossum, M. C. F., Vaage, M. Ø., Ødegård, R., & Vanky, E. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30385-7 · Cited by 134
Peterson, C., Grosse, S. D., Li, R., Sharma, A. J., Razzaghi, H., Herman, W. H., & Gilboa, S. M. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.09.009 · Cited by 130
Wahabi, H. A., Fayed, A., Esmaeil, S., Elmorshedy, H., Titi, M. A., Amer, Y. S., Alzeidan, R. A., Alodhayani, A. A., Saeed, E., Bahkali, K. H., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0237571 · Cited by 130
Li, N., Yang, Y., Cui, D., Li, C., Ma, R. C. W., Li, J., & Yang, X. (2021) · Obesity Reviews · doi:10.1111/obr.13122 · Cited by 129
Laredo-Aguilera, J. A., Gallardo-Bravo, M., Rabanales-Sotos, J. A., Cobo-Cuenca, A. I., & Carmona-Torres, J. M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176151 · Cited by 125
Safety of Insulin Glargine Use in Pregnancy: A Systematic Review and Meta-Analysis
Pollex, E. K., Moretti, M. E., Koren, G., & Feig, D. S. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p327 · Cited by 124
Jiang, Y.-F., Chen, X.-Y., Ding, T., Wang, X.-F., Zhu, Z.-N., & Su, S.-W. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4403 · Cited by 124
Mayo, K., Melamed, N., Vandenberghe, H., & Berger, H. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.08.027 · Cited by 122
Nachum, Z., Zafran, N., Salim, R., Hissin, N., Hasanein, J., Gam Ze Letova, Y., Suleiman, A., & Yefet, E. (2017) · Diabetes Care · doi:10.2337/dc16-2307 · Cited by 118
Motherisk Rounds: Risks of Statin Use During Pregnancy: A Systematic Review
Kazmin, A., Garcia-Bournissen, F., & Koren, G. (2007) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32656-1 · Cited by 117
Metformin compared with glyburide for the management of gestational diabetes
Silva, J. C., Pacheco, C., Bizato, J., de Souza, B. V., Ribeiro, T. E., & Bertini, A. M. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.04.028 · Cited by 115
Sénat, M.-V., Affres, H., Letourneau, A., Coustols-Valat, M., Cazaubiel, M., Legardeur, H., Jacquier, J. F., Bourcigaux, N., Simon, E., Rod, A., et al. (2018) · JAMA · doi:10.1001/jama.2018.4072 · Cited by 114
Werner, E. F., Hauspurg, A. K., & Rouse, D. J. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001115 · Cited by 113
Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus
Persson, B., Swahn, M.-L., Hjertberg, R., Hanson, U., Nord, E., Nordlander, E., & Hansson, L.-O. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00141-9 · Cited by 103
Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations
Bateman, B. T., Patorno, E., Desai, R. J., Seely, E. W., Mogun, H., Dejene, S. Z., Fischer, M. A., Friedman, A. M., Hernandez-Diaz, S., & Huybrechts, K. F. (2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001775 · Cited by 102
A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes
Barbour, L. A., Scifres, C., Valent, A. M., Friedman, J. E., Buchanan, T. A., Coustan, D., Aagaard, K., Thornburg, K. L., Catalano, P. M., Galan, H. L., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.06.013 · Cited by 101
Hod, M., Mathiesen, E. R., Jovanovič, L., McCance, D. R., Ivanisevic, M., Durán-Garcia, S., Brøndsted, L., Nazeri, A., & Damm, P. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.799650 · Cited by 100
García‐Moreno, R. M., Benítez‐Valderrama, P., Barquiel, B., González Pérez‐de‐Villar, N., Hillman, N., Lora Pablos, D., & Herranz, L. (2022) · Diabetic Medicine · doi:10.1111/dme.14703 · Cited by 100
Cyganek, K., Skupien, J., Katra, B., Hebda-Szydlo, A., Janas, I., Trznadel-Morawska, I., Witek, P., Kozek, E., & Malecki, M. T. (2017) · Endocrine · doi:10.1007/s12020-016-1134-z · Cited by 94
Differing causes of pregnancy loss in type 1 and type 2 diabetes
Cundy, T., Gamble, G., Neale, L., Elder, R., McPherson, P., Henley, P., & Rowan, J. (2007) · Diabetes Care · doi:10.2337/dc07-0555 · Cited by 90
Pereira, P. F., Alfenas, R. D. C. G., & Araújo, R. M. A. (2014) · Jornal de Pediatria · doi:10.1016/j.jped.2013.02.024 · Cited by 89
Charron-Prochownik, D., Sereika, S. M., Becker, D., White, N. H., Schmitt, P., Powell, A. B., Diaz, A. M., Jones, J., Herman, W. H., Rodgers Fischl, A. F., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0355 · Cited by 89
Breastfeeding and the basal insulin requirement in type 1 diabetic women
Riviello, C., Mello, G., & Jovanovic, L. G. (2009) · Endocrine Practice · doi:10.4158/ep.15.3.187 · Cited by 87
Nutrition therapy within and beyond gestational diabetes
Hernandez, T. L., Mande, A., & Barbour, L. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.004 · Cited by 86
Interpregnancy Weight Change and Risk of Adverse Pregnancy Outcomes: A Population-based Study
Villamor, E., & Cnattingius, S. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000256801.97592.d6 · Cited by 80
Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes
Law, G. R., Gilthorpe, M. S., Secher, A. L., Temple, R., Bilous, R., Mathiesen, E. R., Murphy, H. R., & Scott, E. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4205-7 · Cited by 77
Ludvigsson, J. F., Neovius, M., Söderling, J., Gudbjörnsdottir, S., Svensson, A.-M., Franzén, S., Stephansson, O., & Pasternak, B. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1974 · Cited by 75
Tarry-Adkins, J. L., Aiken, C. E., & Ozanne, S. E. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003126 · Cited by 73
Impact of type 2 diabetes, obesity and glycaemic control on pregnancy outcomes
Abell, S. K., Boyle, J. A., de Courten, B., Soldatos, G., Wallace, E. M., Zoungas, S., & Teede, H. J. (2017) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12521 · Cited by 70
Pathirana, M. M., Lassi, Z. S., Alì, A., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09587-0 · Cited by 65
Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes
Temple, R., Aldridge, V, Stanley, K., & Murphy, H. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01071.x · Cited by 63
Feig, D. S., Sanchez, J. J., Murphy, K. E., Asztalos, E., Zinman, B., Simmons, D., Haqq, A. M., Fantus, I. G., Lipscombe, L., Armson, A., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00004-9 · Cited by 61
Contemporary type 1 diabetes pregnancy outcomes: impact of obesity and glycaemic control
Abell, S. K., Boyle, J. A., Courten, B., Knight, M., Ranasinha, S., Regan, J., Soldatos, G., Wallace, E. M., Zoungas, S., & Teede, H. J. (2016) · Medical Journal of Australia · doi:10.5694/mja16.00443 · Cited by 60
Ho, Y.-R., Wang, P., Lu, M.-C., Tseng, S.-T., Yang, C.-P., & Yan, Y.-H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177563 · Cited by 59
Mathiesen, J. M., Secher, A. L., Ringholm, L., Nørgaard, K., Hommel, E., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.837444 · Cited by 58
Szmuilowicz, E. D., Levy, C. J., Buschur, E. O., & Polsky, S. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0540 · Cited by 58
Self-citationPadmanabhan, S., Lee, V. W., Mclean, M., Athayde, N., Lanzarone, V., Khoshnow, Q., Peek, M. J., & Cheung, N. W. (2017) · Diabetes Care · doi:10.2337/dc17-0391 · Cited by 55
Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus
Malek, R., & Davis, S. N. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1187131 · Cited by 54
Relph, S., Patel, T., Delaney, L., Sobhy, S., & Thangaratinam, S. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003856 · Cited by 54
Peripartum management of glycemia in women with type 1 diabetes
Achong, N., Duncan, E. L., McIntyre, H. D., & Callaway, L. (2014) · Diabetes Care · doi:10.2337/dc13-1348 · Cited by 53
Werner, E. F., Has, P., Rouse, D., & Clark, M. A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.05.036 · Cited by 52
Mathiesen, E. R., Alibegovic, A. C., Corcoy, R., Dunne, F., Feig, D. S., Hod, M., Jia, T., Kalyanam, B., Kar, S., Kautzky-Willer, A., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00307-2 · Cited by 52
Widyaputri, F., Rogers, S. L., Kandasamy, R., Shub, A., Symons, R. C. A., & Lim, L. L. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2022.0050 · Cited by 49
Metformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach
Barbour, L. A., & Feig, D. S. (2019) · Diabetes Care · doi:10.2337/dci18-0055 · Cited by 44
Should women with gestational diabetes be screened at delivery hospitalization for type 2 diabetes?
Waters, T. P., Kim, S. Y., Werner, E., Dinglas, C., Carter, E. B., Patel, R., Sharma, A. J., & Catalano, P. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.07.035 · Cited by 44
Long-acting Reversible Contraception—Highly Efficacious, Safe, and Underutilized
Wu, J. P., Moniz, M. H., & Ursu, A. (2018) · JAMA · doi:10.1001/jama.2018.8877 · Cited by 44
Fetal growth in women managed with insulin pump therapy compared to conventional insulin
Kernaghan, D., Farrell, T., Hammond, P., & Owen, P. (2008) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.05.006 · Cited by 42
(1986) · PubMed · Cited by 41
Doi, S. A. R., Furuya‐Kanamori, L., Toft, E., Musa, O. A. H., Islam, N., Clark, J., & Thalib, L. (2020) · Obesity Reviews · doi:10.1111/obr.12964 · Cited by 39
Time in range in pregnancy: is there a role?
Wyckoff, J. A., & Brown, F. M. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0103 · Cited by 39
Nørgaard, S. K., Mathiesen, E. R., Nørgaard, K., & Ringholm, L. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0109 · Cited by 38
Contraceptive Use Among Women with Prediabetes and Diabetes in a US National Sample
Britton, L. E., Hussey, J. M., Berry, D. C., Crandell, J., Brooks, J. L., & Bryant, A. G. (2018) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12936 · Cited by 35
de Veciana, M., Major, C. A., Morgan, M. A., Asrat, T., Toohey, J. S., Lien, J. M., & Evans, A. T. (1996) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199604000-00002 · Cited by 34
Fetal growth is increased by maternal type 1 diabetes and HLA DR4-related gene interactions
Hummel, M., Marienfeld, S., Huppmann, M., Knopff, A., Voigt, M., Bonifacio, E., & Ziegler, A.-G. (2007) · Diabetologia · doi:10.1007/s00125-007-0607-2 · Cited by 29
Ahmed, R. J., Gafni, A., Hutton, E. K., Hu, Z. J., Sanchez, J. J., Murphy, H. R., & Feig, D. S. (2021) · CMAJ Open · doi:10.9778/cmajo.20200128 · Cited by 29
The Intrauterine Device in Women with Diabetes Mellitus Type I and II: A Systematic Review
Goldstuck, N. D., & Steyn, P. S. (2013) · ISRN Obstetrics and Gynecology · doi:10.1155/2013/814062 · Cited by 29
Pathirana, M. M., Ali, A., Lassi, Z. S., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2022) · Journal of Human Lactation · doi:10.1177/08903344211034779 · Cited by 29
Neoh, S. L., Grisoni, J. A., Feig, D. S., Murphy, H. R., & the CONCEPTT Collaborative Group (2020) · Diabetic Medicine · doi:10.1111/dme.13937 · Cited by 26
Hod, M., Mathiesen, E. R., Jovanovič, L., McCance, D. R., Ivanišević, M., Durán-Garcia, S., Brøndsted, L., Nazeri, A., & Damm, P. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.783809 · Cited by 26
Sarvepalli, S. M., Bailey, B. A., D'Alessio, D., Lemaitre, M., Vambergue, A., Rathinavelu, J., & Hadziahmetovic, M. (2023) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.14168 · Cited by 24
Martínez‐Hortelano, J. A., Cavero‐Redondo, I., Álvarez‐Bueno, C., Díez‐Fernández, A., Hernández‐Luengo, M., & Martínez‐Vizcaíno, V. (2021) · Obesity · doi:10.1002/oby.23083 · Cited by 19
Aspirin for the prevention of preeclampsia and potential consequences for fetal brain development
Voutetakis, A., Pervanidou, P., & Kanaka-Gantenbein, C. (2019) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2019.1260 · Cited by 18
Bartal, M. F., Ward, C., Blackwell, S. C., Cornthwaite, J. A. A., Zhang, C., Refuerzo, J., Pedroza, C., Lee, K. H., Chauhan, S. P., & Sibai, B. M. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.04.223 · Cited by 18
Ramos, D. E. (2019) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2019.04.001 · Cited by 17
Morris, J. R., & Tepper, N. K. (2019) · Contraception · doi:10.1016/j.contraception.2019.08.008 · Cited by 16
Suhonen, L., Hiilesmaa, V., & Teramo, K. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200008000-00007 · Cited by 14
Aspirin for the prevention of pre-eclampsia in women with pre-existing diabetes: systematic review
Zen, M., Haider, R., Simmons, D., Peek, M., Nolan, C. J., Padmanabhan, S., Jesudason, S., Alahakoon, T. I., Cheung, N. W., & Lee, V. W. (2022) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13460 · Cited by 13
Widyaputri, F., Rogers, S., & Lim, L. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2022.3722 · Cited by 10
Feig, D. S., Donovan, L., Corcoy, R., Murphy, K. E., & Amiel, S. A. (2018) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000542359.79329.36 · Cited by 8
Hoffman, M., Goudar, S. S., Kodkany, B. S., Metgud, M. C., Somannavar, M. S., Okitawutshu, J., Lokangaka, A. L., Tshefu, A. K., Bose, C. L., Tembo, A. M., et al. (2020) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000719608.24257.dc
Incidence Rate of Type 2 Diabetes Mellitus after Gestational Diabetes MellitusPreprint
Li, Z., Cheng, Y., Wang, D., Chen, H., Chen, H., Ming, W., & Wang, Z. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3373852
Peterson, C., Grosse, S. D., Li, R., Sharma, A. J., Razzaghi, H., Herman, W. H., & Gilboa, S. M. (2016) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000479522.11533.77
Balsells, M., García-Patterson, A., Solà, I., Roqué, M., Gich, I., & Corcoy, R. (2015) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000472700.65844.d9
Brown, M., Magee, L., Kenny, L., et al. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2018.08.022
Koivusalo, S. B., Rönö, K., Klemetti, M. M., Roine, R. P., Lindström, J., Erkkola, M., Kaaja, R. J., Pöyhönen-Alho, M., Tiitinen, A., Huvinen, E., et al. (2017) · Diabetes Care · doi:10.2337/dc17-er08a
Research works printed but not linked: 2
- 2006, Dietary Reference Intakes: The Essential Guide to Nutrient Requirements
- Henderson JT , VescoKK, SengerCA, . Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality (Evidence Synthesis, no. 205). Rockville, MD, Agency for Healthcare Research and Quality. Accessed 17 October 2023. Available from https://www.ncbi.nlm.nih.gov/books/NBK574449/
Cited by
Magnesium Matters: A Comprehensive Review of Its Vital Role in Health and Diseases
Fatima, G., Džupina, A., Al-Hmadi, H. B., Magomedova, A. G., Siddiqui, Z., Mehdi, A., & Hadi, N. R. (2024) · Cureus · doi:10.7759/cureus.71392 · Cited by 155
“Mg requirements are higher for adolescents, individuals with high physical activity levels, and those with certain medical conditions such as diabetes and hypertension [11].”
Wyckoff, J., Lapolla, A., Asias-Dinh, B. D., Barbour, L. A., Brown, F. M., Catalano, P. M., Corcoy, R., Renzo, G. C. D., Drobycki, N., Kautzky‐Willer, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf288 · Cited by 59
Crawford, A. L., & Laiteerapong, N. (2024) · Annals of Internal Medicine · doi:10.7326/aitc202406180 · Cited by 54
Metformin beyond type 2 diabetes: Emerging and potential new indications
Petrie, J. R. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15756 · Cited by 53
Reddy, M., & Oliver, N. S. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15504 · Cited by 47
“33 The ADA standards also highlight that those offered rtCGM have to be capable of using the devices safely (either by themselves or with a caregiver) and that the choice of device should be made based on the individual's circumstances, preferences and needs.”
Background
Metadata
- Authors
- American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., Lingvay, I., Matfin, G., McCoy, R. G., Perry, M. L., Pilla, S. J., Polsky, S., Prahalad, P., Pratley, R. E., Segal, A. R., Seley, J. J., Stanton, R. C., & Gabbay, R. A.
- ORCID
- ElSayed, Nuha A.
- Aleppo, Grazia
- Bannuru, Raveendhara R.
- Bruemmer, Dennis
- Collins, Billy S.
- Ekhlaspour, Laya
- Hilliard, Marisa E.
- Johnson, Eric L.
- Khunti, Kamlesh
- Lingvay, Ildiko
- McCoy, Rozalina G.
- Perry, Mary Lou
- Pilla, Scott J.
- Polsky, Sarit
- Prahalad, Priya
- Pratley, Richard E.
- Segal, Alissa R.
- Seley, Jane Jeffrie
- Stanton, Robert C.
- Gabbay, Robert A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2023-12-11
- Volume
- 47
- Issue
- Supplement_1
- Pages
- S282-S294
- ISSN
- 0149-5992 (ISSN-L)
- PMC
- PMC10725801
- OpenAlex
- W4389560993
- Semantic Scholar
- 1f3e4a9c0ae2be86d5da282aa96908a6bda368a2
- Cited by
- 232
- References
- 147
- Citations by year
- 2026: 60 · 2025: 106 · 2024: 66
- FWCI
- 14.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK121942)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- diabetes in pregnancy, gestational diabetes mellitus, clinical guidelines, treatment goals, quality of care
- MeSH terms
- Diabetes Mellitus, Endocrinology, Female, Humans, Pregnancy, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.